Get started
Author

Mar Martín‐Pérez

Observed names: M Martín-Pérez, M. Martin-Perez, M. Martín-Pérez, Mar Martin-Perez, Mar Martin-Pérez, Mar Martín Pérez, Mar Martín-Perez, Mar Martín-Pérez, Martin-Perez, Mar, Martín-Pérez M, Martín-Pérez, Mar
ORCID: 0000-0002-5376-2549
Observed ORCID: 0000-0002-5376-2549
OpenAlex ID: A5012677155
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
2016 · Luis A. García Rodríguez, Mar Martín-Pérez, et al. · PLoS ONE · 211
PDF
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
2015 · Yunxia Lu, Luis Alberto García Rodríguez, et al. · British Journal of Cancer · 84
PDF
Risk Factors for Hyperkalaemia in a Cohort of Patients with Newly Diagnosed Heart Failure: A Nested Case–Control Study in UK General Practice
2015 · Alexander Michel, Mar Martín-Pérez, et al. · European Journal of Heart Failure · 69
PDF
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
2022 · C Willame, C Dodd, et al. · Vaccine · 67
Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
2019 · Luis Alberto García Rodríguez, Mar Martín-Pérez, et al. · BMJ Open · 52
PDF
Prevalencia de polifarmacia en la población mayor de 65 años en España: análisis de las Encuestas Nacionales de Salud 2006 y 2011/12
2016 · Mar Martin-Pérez, Ana López de Andrés, et al. · Revista Española de Geriatría y Gerontología · 44
Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality
2016 · Ana Ruigómez, Alexander Michel, et al. · International Journal of Cardiology · 35
Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
2022 · Sophie H. Bots, Judit Riera-Arnau, et al. · Frontiers in Pharmacology · 30
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study
2023 · Shahab Abtahi, Romin Pajouheshnia, et al. · Drug Safety · 27
PDF
Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach
2018 · Mar Martín-Pérez, David Gaist, et al. · Thrombosis and Haemostasis · 26
Predictors of medication use in the Roma population in Spain: a population-based national study
2015 · M. Martín-Pérez, V. Hernández Barrera, et al. · Public Health · 23
Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case–control analyses
2019 · Mar Martín-Pérez, Alexander Michel, et al. · BMJ Open · 20
PDF
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries
2023 · Fabio Riefolo, Belén Castillo-Cano, et al. · Vaccine · 18
Predictors of Over-Anticoagulation in Warfarin Users in the UK General Population: A Nested Case–Control Study in a Primary Health Care Database
2018 · Mar Martín-Pérez, David Gaist, et al. · Thrombosis and Haemostasis · 18
Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events
2014 · Ana Ruigómez, Saga Johansson, et al. · BMC Gastroenterology · 15
PDF
Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure
2016 · Mar Martín-Pérez, Ana Ruigómez, et al. · Journal of Cardiovascular Medicine · 13
Parental administration of over‐the‐counter medication to Spanish children: A population‐based national study
2016 · Mar Martín‐Pérez, Ana López De Andrés, et al. · Journal for Specialists in Pediatric Nursing · 12
Multiple vertebral fractures after antiosteoporotic medications discontinuation: A comparative study to evaluate the potential rebound effect of denosumab
2024 · Mar Martín-Pérez, Beatriz Sánchez-Delgado, et al. · Bone · 10
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis
2023 · Carlos E. Durán, Judit Riera-Arnau, et al. · Frontiers in Pharmacology · 10
PDF
Incidence and risk factors for severe renal impairment after first diagnosis of heart failure: A cohort and nested case–control study in UK general practice
2016 · Alexander Michel, Mar Martín-Pérez, et al. · International Journal of Cardiology · 10
Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain
2021 · Elisa Martín-Merino, Belen Castillo-Cano, et al. · Vaccine · 8
Number of Medications and Mortality Among Residents in Nursing Homes
2019 · Mar Martín-Pérez, Ana Ruigómez, et al. · Journal of the American Medical Directors Association · 8
Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care
2016 · Mar Martín-Pérez, Ana Ruigómez, et al. · BMC Family Practice · 8
PDF
Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9–18 years: A time-varying cohort study
2022 · Belén Castillo-Cano, Mar Martín-Pérez, et al. · Vaccine · 7
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example
2024 · Sophie H Bots, Svetlana Belitser, et al. · American Journal of Epidemiology · 6
Works count: 45
Citation count: 864
H-index: 15
I10-index: 20
Year
Topic
Type